Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02908711
Other study ID # 0524-16-RMC
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date October 2016
Est. completion date January 2018

Study information

Verified date August 2016
Source Rabin Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Total knee arthroplasty (TKA) is associated with severe postoperative pain. Multimodal analgesia, including peripheral nerve block, is recommended for post-operative pain relief 1. Perineural analgesia offers the advantage of extended pain relief up to 24 hours after surgery2.

This is a prospective, randomized control trial designed to compare the analgesic efficacy of the adductor canal block (ACB) performed immediately before or immediately after primary total knee arthroplasty (TKA). The primary objective of this study is to measure pain score associated with knee motion following TKA among patients receiving ACB as part of their analgesic regimen for TKA. Secondary end points include assessment of postoperative ambulation, range of motion, pain at rest, opioid consumption, and patient satisfaction between the two analgesic approaches. The investigators hypothesize that ACB before the surgery will reduce a patient's postoperative pain and improve patient satisfaction.

All consecutive patients undergoing primary TKA will be recruited for enrollment in the study. Patients will be for randomized preoperatively to receive either preemptive ABC (PreACB) or postoperative ABC (PostACB). Patients randomized to the PreACB group will receive the block prior to incision. Patients randomized to the PostACB group will receive the block at the end of the surgery. Both techniques are in accordance to the standard of care at our institute. All patients will have the ACB done by a regional anesthesiologist in the regional anesthesia unit, or in the operating room. Patient medical history will be obtained and blocks will be placed per usual protocol. Operative and anesthetic details, including medications given, will be recorded.

Pain scores and pain medications given in the PACU will be recorded. Supplementary analgesics will be provided per institutional PACU protocol. Study data will be recorded for up to 72 hours or until patient discharge. A follow-up will occur in 4- 6 weeks at the orthopedic follow-up appointment to evaluate the patient's late pain scores and overall satisfaction. Data will be analyzed both at the conclusion of the study and at several intervals prior to completion of the study.


Description:

D. Research Design and Methods

Inclusion Criteria:

The study is a prospective, randomized controlled clinical trial comparing two methods of regional analgesia for primary TKA. All adult primary TKA patients are eligible for inclusion in the study.

Exclusion criteria:

- Allergy to local anesthetics or to systemic opioids

- Contraindication to regional anesthesia technique, such as local infection or coagulopathy

- Sensory/motor disorder involving operative limb

- Requirements of more than 30 mg morphine equivalent daily prior to surgery

- ASA 4 or greater

- Psychiatric or cognitive disorders

- Incarceration

- Renal insufficiency with Cr > 2.0

- Hepatic failure

- Pregnancy

- Age under 18 years Potential risks for the procedure, which will be explained to the patient, include: bleeding, local infection, local anesthetic toxicity. All are commonly listed as rare complications of the procedures.

After consenting to participation and upon randomization, ACBs will be placed either in the regional anesthesia bay or the OR prior to anesthesia induction and surgery, or in the OR immediately upon completion of surgery.

For participating patients, the following data will be collected by the research staff: ASA physical status, age, height, weight, gender, intra- and post operative quantitative opiate use (expressed as morphine equivalent), numeric VAS scores, KSS score (form included) and QoR score (form included).

Those collecting data will be blinded from randomization of patients to either research group.

Intraoperative care:

Intraoperative anesthesia will be achieved using a general anesthetic technique. Intraoperative analgesia will be administered per anesthesiologists' discretion.

All patients will have cemented total knee utilizing a medial parapatellar approach, including patellar resurfacing. A tourniquet will be used in all cases. Posterior capsule infiltration will be done with 20cc of 0.25% bupivacaine, as the preferred method of providing sacral plexus analgesia 5-6, per current institutional protocol.

ACB Procedure Details Patients will lie in the supine position. The needle insertion site, approximately 10cm proximal to their operative knee, will be exposed. The skin will be disinfected with 2% Chlorhexidine and the ultrasound probe placed in a sterile sleeve. The femoral artery is identified with a high frequency linear transducer (Philips 4-12L linear transducer with a frequency of 6-12 MHz, Milwaukee, WI or ) proximal to the operative knee. The appropriate location for injection will be determined by following the femoral artery cephalad until the artery is directly posterior to the Sartorius muscle. At this level, the saphenous nerve is located lateral to the femoral artery. An 18g insulated sonographic Tuohy needle (Pajunk GmbH, Geisingen, Germany) will be inserted in an in-plane approach, under constant ultrasound visualization, through the Sartorius muscle to a final location in close proximity to the saphenous nerve. Once satisfied with needle placement and following negative aspiration, 20 cc of 0.5% ropivacaine will be injected gradually through the needle under visualization, with recurrent aspirations to verify absence of intra-vascular injection signs.

Data Collection Patients will be enrolled for the study during the orthopedic surgical appointment upon the scheduling of the surgery. Upon enrollment, patients will complete a baseline KSS questionnaire (attached), have a VAS pain score recorded, and have their pre-operative analgesic medication documented.

To assess the effect of pain with movement and overall strength, on POD 1, the patient will indicate their level of pain using VAS numeric scale (1-10). QoR questionnaire (attached) will be assessed 24 hours from the placement of the ACB. Overall analgesic medication consumption, both opioid (expressed as morphine equivalent) and non-opioid will be recorded for PODs 1-3.

The patients will also complete the KSS and the QoR questionnaires at the 4-6 week orthopedic follow-up appointment, as VAS scores and total analgesic medication will be documented.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

The study is a prospective, randomized controlled clinical trial comparing two methods of regional analgesia for primary TKA. All adult primary TKA patients are eligible for inclusion in the study.

Exclusion Criteria:

- Allergy to local anesthetics or to systemic opioids

- Contraindication to regional anesthesia technique, such as local infection or coagulopathy

- Sensory/motor disorder involving operative limb

- Requirements of more than 30 mg morphine equivalent daily prior to surgery

- ASA 4 or greater

- Psychiatric or cognitive disorders

- Incarceration

- Renal insufficiency with Cr > 2.0

- Hepatic failure

- Pregnancy

- Age under 18 years

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
0.5% ropivacaine
Adductor canal block (ACB) performed as part of their analgesic regimen for primary total knee arthroplasty achieved with 20 cc of 0.5% ropivacaine under constant ultrasound visualization.

Locations

Country Name City State
Israel Rabin Medical Center Petach Tikvah

Sponsors (1)

Lead Sponsor Collaborator
Rabin Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (10)

Essving P, Axelsson K, Åberg E, Spännar H, Gupta A, Lundin A. Local infiltration analgesia versus intrathecal morphine for postoperative pain management after total knee arthroplasty: a randomized controlled trial. Anesth Analg. 2011 Oct;113(4):926-33. doi: 10.1213/ANE.0b013e3182288deb. Epub 2011 Aug 4. — View Citation

Fischer HB, Simanski CJ, Sharp C, Bonnet F, Camu F, Neugebauer EA, Rawal N, Joshi GP, Schug SA, Kehlet H; PROSPECT Working Group. A procedure-specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia. 2008 Oct;63(10):1105-23. doi: 10.1111/j.1365-2044.2008.05565.x. Epub 2008 Jul 10. Review. — View Citation

Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989 Nov;(248):13-4. — View Citation

Jenstrup MT, Jæger P, Lund J, Fomsgaard JS, Bache S, Mathiesen O, Larsen TK, Dahl JB. Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand. 2012 Mar;56(3):357-64. doi: 10.1111/j.1399-6576.2011.02621.x. Epub 2012 Jan 4. — View Citation

Kang H, Ha YC, Kim JY, Woo YC, Lee JS, Jang EC. Effectiveness of multimodal pain management after bipolar hemiarthroplasty for hip fracture: a randomized, controlled study. J Bone Joint Surg Am. 2013 Feb 20;95(4):291-6. doi: 10.2106/JBJS.K.01708. — View Citation

Kazak Bengisun Z, Aysu Salviz E, Darcin K, Suer H, Ates Y. Intraarticular levobupivacaine or bupivacaine administration decreases pain scores and provides a better recovery after total knee arthroplasty. J Anesth. 2010 Oct;24(5):694-9. doi: 10.1007/s00540-010-0970-x. Epub 2010 Jun 23. — View Citation

Melvin JS, Stryker LS, Sierra RJ. Tranexamic Acid in Hip and Knee Arthroplasty. J Am Acad Orthop Surg. 2015 Dec;23(12):732-40. doi: 10.5435/JAAOS-D-14-00223. Epub 2015 Oct 22. Review. — View Citation

Myles PS, Hunt JO, Nightingale CE, Fletcher H, Beh T, Tanil D, Nagy A, Rubinstein A, Ponsford JL. Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg. 1999 Jan;88(1):83-90. — View Citation

Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. — View Citation

O'Donnell BD, Iohom G. Regional anesthesia techniques for ambulatory orthopedic surgery. Curr Opin Anaesthesiol. 2008 Dec;21(6):723-8. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain score associated with knee motion following TKA This study's primary endpoint the change in the patient's reported pain score on the preoperative visit, on postoperative day (POD) 1, and the patient's pain score reported on the 4-6 week follow- up visit. Pain score will be measured using a numeric verbal analogue scale (1-10). Pain will be measured using this scale on the pre-operative visit, and on POD1 prior to manipulation, with active (patient driven) movement and with passive (physician elicited) movement. 4-6 Weeks postoperatively
Secondary Opioid consumption This study secondary endpoints is to evaluate changes in opioid consumption throughout 24-48 hours postoperatively to the 4-6 weeks postoperatively.Opioid consumption will be documented by a member of the research team at 24 hours postoperatively, 48 hours postoperatively , and on the follow-up visit (4-6 weeks postoperatively) in order to identify reduction / increases in patient's opioid consumption trends. 4-6 weeks postoperatively
Secondary Patient satisfaction between the two analgesic approaches. Additional secondary endpoint of this study is to evaluate whether patient's satisfaction scores differ amongst the two analgesic approaches on the POD 1. Patient's satisfaction score will be measured using the Quality of Recovery (QoR) score, documented on POD 1. 24 hours postoperatively
Secondary Assessment of postoperative ambulation. Additional secondary endpoint of this study include assessment of changes in ambulation the range of motion throughout the study participation, from the preoperative visit to the follow-up visit (4-6 weeks following surgery). Knee Society Score (KSS) will be documented on preoperative visit, on POD 1 and at the follow-up visit ( 4-6 weeks after surgery), to examine changes in ambulation. 4-6 weeks postoperatively
Secondary Assessment of postoperative pain at rest Additional secondary endpoint of this study include assessment of changes in pain at rest using the KSS score throughout the study participation, from the preoperative visit to the follow-up visit (4-6 weeks following surgery). Knee Society Score (KSS) will be documented on preoperative visit, on POD 1 and at the follow-up visit ( 4-6 weeks after surgery), to examine changes in patients reported pain at rest. 4-6 weeks postoperatively
Secondary Thrombo-embolic complications Complications of deep venous thrombosis, pulmonary embolus will be documented Up to 24 weeks
Secondary Blood transfusion Additional secondary endpoint of this study is to assess whether the different analgesic approaches effect bleeding complications, measured by the number of patients who receive transfusion of concentrated blood cells units throughout their hospital admission. Up to 24 weeks
Secondary Non opioid analgesia consumption This study secondary endpoints is to evaluate changes in non-opioid analgesia -non opioid medication consumption throughout 24-48 hours postoperatively to the 4-6 weeks after surgery. Non-opioid analgesia - non-opioid medication consumption will be recorded on pre-operative visit, on POD 1, and on the follow-up visit (4-6 weeks postoperatively) in order to identify reduction / increases in patient's non-opioid analgesia -non opioid medication consumption trends. 4-6 weeks postoperatively
Secondary Patient satisfaction with the two analgesic approaches 4-6 weeks postopertively Additional secondary endpoint of this study is to evaluate whether patient's satisfaction scores differ among the two analgesic approaches at the follow-up visit (4-6 weeks postoperatively). Patient's satisfaction score will be measured using the Quality of Recovery (QoR) score, documented on follow-up visit. 4-6 weeks postoperatively
Secondary Abnormal hemoglobin concentration values Additional secondary endpoint of this study is to assess whether the different analgesic approaches effect bleeding complications, measured by the percent of decline in patients' hemoglobin concentration throughout their hospital admission. Up to 24 weeks
Secondary Duration of hospital stay Additional secondary endpoint of this study is to assess whether the different analgesic approaches effect duration of hospital admission, measured by the length of stay in the hospital. Up to 24 weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT04053491 - Comparison of the Infraclavicular and Axillary Approaches for Continuous Ultrasound-guided Brachial Plexus Block. N/A
Completed NCT05096377 - Hemi-diaphragmatic Paresis and Erector Spinae Plane Block
Completed NCT03310047 - Intra-individual Reproducibility in Nerve Block Duration Phase 1
Completed NCT04201678 - Effectiveness of Erector Spinae Block in Kyphoplasty N/A
Completed NCT04193488 - Mid-Transverse Process to Pleural (MTP) Block and Erector Spinal Plan (ESP) Block in Spinal Surgery N/A
Completed NCT02879916 - Comparison of an Interscalene Nerve Block With or Without Stellate Ganglion Block for Shoulder Surgery Phase 4
Recruiting NCT05100706 - Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty N/A
Completed NCT04102358 - The Need for Supplemental Blocks in Infraclavicular Brachial Plexus Blocks
Completed NCT03923751 - Survey of Regional Anesthesia Practice in Poland
Completed NCT03038425 - Does Continuous Adductor Canal Nerve Block Improve the Quality of Recovery for Outpatient Total Knee Arthroplasty Patients? N/A
Completed NCT05802589 - Comparison of the Efficiency of PENG Block and ESP Block Used for Postoperative Analgesia in Elective Hip Surgery N/A
Recruiting NCT03449680 - The Analgesic Efficacy of the Ultrasound-Guided Femoral Articular Branch Block for Ambulatory Hip Arthroscopy N/A
Not yet recruiting NCT03155568 - Safety and Efficacy of Three Local Block Techniques for Diabetic Foot Surgery N/A
Completed NCT03729635 - Pectoral-Intercostal Fascial Plane Block Study N/A
Not yet recruiting NCT06203743 - Evaluation of Caudal Block and Ilioinguinal-ilioohypogastric Nerve Block Efficacy With Perfusion Index (PI) N/A
Completed NCT06201546 - Comparison of Abdominal Plane Blocks in Postoperative Pain Control in Patients Undergoing LSG N/A
Not yet recruiting NCT05734469 - Difference in Occurrence of Rebound Pain in Patients Undergoing Surgery Under Popliteal Block or Ankle Block N/A
Not yet recruiting NCT04301687 - FAB Block vs. Placebo for Hip Arthroplasty Patients N/A
Completed NCT04286035 - Two Different Blocks for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty Phase 4
Not yet recruiting NCT06316596 - Brain Oxygenation in Newborns Due to Neuroaksial Methods N/A